These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 10518181)

  • 1. Comparison of ketamine-induced thought disorder in healthy volunteers and thought disorder in schizophrenia.
    Adler CM; Malhotra AK; Elman I; Goldberg T; Egan M; Pickar D; Breier A
    Am J Psychiatry; 1999 Oct; 156(10):1646-9. PubMed ID: 10518181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attenuation of the neuropsychiatric effects of ketamine with lamotrigine: support for hyperglutamatergic effects of N-methyl-D-aspartate receptor antagonists.
    Anand A; Charney DS; Oren DA; Berman RM; Hu XS; Cappiello A; Krystal JH
    Arch Gen Psychiatry; 2000 Mar; 57(3):270-6. PubMed ID: 10711913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers: implications for models of cognitive deficits in schizophrenia.
    Umbricht D; Schmid L; Koller R; Vollenweider FX; Hell D; Javitt DC
    Arch Gen Psychiatry; 2000 Dec; 57(12):1139-47. PubMed ID: 11115327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Glutaminergic hypothesis of schizophrenia: clinical research studies with ketamine].
    Mechri A; Saoud M; Khiari G; d'Amato T; Dalery J; Gaha L
    Encephale; 2001; 27(1):53-9. PubMed ID: 11294039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychological effects of (S)-ketamine and N,N-dimethyltryptamine (DMT): a double-blind, cross-over study in healthy volunteers.
    Gouzoulis-Mayfrank E; Heekeren K; Neukirch A; Stoll M; Stock C; Obradovic M; Kovar KA
    Pharmacopsychiatry; 2005 Nov; 38(6):301-11. PubMed ID: 16342002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses.
    Krystal JH; Karper LP; Seibyl JP; Freeman GK; Delaney R; Bremner JD; Heninger GR; Bowers MB; Charney DS
    Arch Gen Psychiatry; 1994 Mar; 51(3):199-214. PubMed ID: 8122957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NMDA receptor function and human cognition: the effects of ketamine in healthy volunteers.
    Malhotra AK; Pinals DA; Weingartner H; Sirocco K; Missar CD; Pickar D; Breier A
    Neuropsychopharmacology; 1996 May; 14(5):301-7. PubMed ID: 8703299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive substrates of thought disorder, I: the semantic system.
    Goldberg TE; Aloia MS; Gourovitch ML; Missar D; Pickar D; Weinberger DR
    Am J Psychiatry; 1998 Dec; 155(12):1671-6. PubMed ID: 9842774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The NMDA antagonist model for schizophrenia: promise and pitfalls.
    Abi-Saab WM; D'Souza DC; Moghaddam B; Krystal JH
    Pharmacopsychiatry; 1998 Jul; 31 Suppl 2():104-9. PubMed ID: 9754841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics.
    Malhotra AK; Pinals DA; Adler CM; Elman I; Clifton A; Pickar D; Breier A
    Neuropsychopharmacology; 1997 Sep; 17(3):141-50. PubMed ID: 9272481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of ketamine on leading saccades during smooth-pursuit eye movements may implicate cerebellar dysfunction in schizophrenia.
    Avila MT; Weiler MA; Lahti AC; Tamminga CA; Thaker GK
    Am J Psychiatry; 2002 Sep; 159(9):1490-6. PubMed ID: 12202268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preliminary analysis of positive and negative syndrome scale in ketamine-associated psychosis in comparison with schizophrenia.
    Xu K; Krystal JH; Ning Y; Chen DC; He H; Wang D; Ke X; Zhang X; Ding Y; Liu Y; Gueorguieva R; Wang Z; Limoncelli D; Pietrzak RH; Petrakis IL; Zhang X; Fan N
    J Psychiatr Res; 2015 Feb; 61():64-72. PubMed ID: 25560772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clozapine blunts N-methyl-D-aspartate antagonist-induced psychosis: a study with ketamine.
    Malhotra AK; Adler CM; Kennison SD; Elman I; Pickar D; Breier A
    Biol Psychiatry; 1997 Oct; 42(8):664-8. PubMed ID: 9325559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of ketamine-induced psychosis with focal activation of the prefrontal cortex in healthy volunteers.
    Breier A; Malhotra AK; Pinals DA; Weisenfeld NI; Pickar D
    Am J Psychiatry; 1997 Jun; 154(6):805-11. PubMed ID: 9167508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nicotine fails to attenuate ketamine-induced cognitive deficits and negative and positive symptoms in humans: implications for schizophrenia.
    D'Souza DC; Ahn K; Bhakta S; Elander J; Singh N; Nadim H; Jatlow P; Suckow RF; Pittman B; Ranganathan M
    Biol Psychiatry; 2012 Nov; 72(9):785-94. PubMed ID: 22717030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of thought disorders on quality of life in patients with schizophrenia.
    Ulas H; Akdede BB; Ozbay D; Alptekin K
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):332-5. PubMed ID: 17854967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S-Ketamine-Induced NMDA Receptor Blockade during Natural Speech Production and Its Implications for Formal Thought Disorder in Schizophrenia: A Pharmaco-fMRI Study.
    Nagels A; Cabanis M; Oppel A; Kirner-Veselinovic A; Schales C; Kircher T
    Neuropsychopharmacology; 2018 May; 43(6):1324-1333. PubMed ID: 29105665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-methyl-D-aspartate receptor in working memory impairments in schizophrenia: event-related potential study of late stage of working memory process.
    Ahn KH; Youn T; Cho SS; Ha TH; Ha KS; Kim MS; Kwon JS
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Sep; 27(6):993-9. PubMed ID: 14499316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered NMDA glutamate receptor antagonist response in individuals with a family vulnerability to alcoholism.
    Petrakis IL; Limoncelli D; Gueorguieva R; Jatlow P; Boutros NN; Trevisan L; Gelernter J; Krystal JH
    Am J Psychiatry; 2004 Oct; 161(10):1776-82. PubMed ID: 15465973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of ketamine on thought disorder, working memory, and semantic memory in healthy volunteers.
    Adler CM; Goldberg TE; Malhotra AK; Pickar D; Breier A
    Biol Psychiatry; 1998 Jun; 43(11):811-6. PubMed ID: 9611670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.